Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Humpy Dumpy Trumpy...
View:
Post by skier59 on Dec 22, 2020 7:54pm

Humpy Dumpy Trumpy...

is threatening to Veto the COVID relief package. When the fluck will this IDIOT start thinking about the American PEOPLE and not just his FAMILY.....LOCK HIM UP !
Comment by charlierock on Dec 22, 2020 8:27pm
Yes TRESONOUS TRUMP has sunk to a new low when the Devils Deciple himself Pat Robertson has accused Trump of not living in reality.
Comment by skier59 on Dec 22, 2020 8:46pm
....and I wonder how many Republicans are in desperate need of the help.....hopefully 88%.
Comment by charlierock on Dec 22, 2020 9:03pm
CNN's Brian Stelter compares Americans radicalized by right - wing media to ISIS terrorists and mass shooters. Yup the biggest threat to freedom and democracy is internal not external. How's that wall coming? Oh I forgot Mexico's paying for it!!
Comment by Sunvalley on Dec 22, 2020 9:22pm
The COVID releif package includes the following...10 million dollars tp Pakastan for "gender programs" ; 169 million dollars to Vietnam ; 200 million to Bangladsh ; 130 million dollars to Napal for development programs ; 15 million dollars to Pakistan for "democracy programs" ;15 million dollars to Sri Lanka for refurbishing a type of patrol boat ; 500 million to various ...more  
Comment by StevenBirch on Dec 22, 2020 9:56pm
Good one Sun!
Comment by Sunvalley on Dec 22, 2020 9:56pm
......453 million dollars for "assistance to the Ukraine" ; 132 million dollars for "assistance " to Georgia ; Unspecified amounts of dollars to Columbia , Peru , Ecuador and Trinidad for "assistance for communities in these countries impacted by refugees from Venezuela. ; unspecified funds going to Kabul , Afghanistan to support "higher education" ; US ...more  
Comment by Pandora on Dec 22, 2020 11:57pm
Sunvalley, keep in mind that you are talking to some guy that has Brian Stelter as his idol of journalism.
Theralase Technologies Inc.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT

Visit Facebook Visit X Visit Linked In Visit Instagram Visit Youtube



INVESTORS & MEDIA OVERVIEW FINANCIAL FILINGS PRESENTATIONS MEDIA FACT SHEETS MANAGEMENT

Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250